U.S. Influenza Surveillance 2004 - 2005 Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.

Slides:

Advertisements

Similar presentations

Surveillance in a Pandemic: Situational Awareness

Advertisements

INFLUENZA DIVISION U.S. Influenza Surveillance Update, Season Joseph Bresee, MD Epidemiology and Prevention Branch, Influenza Division, CDC VRBPAC.

Interpreting and Describing Data. General Considerations Correct interpretation depends on your being very familiar with your data –Ongoing process that.

Influenza Surveillance

H3N2 variant influenza A Maine, 2011 Sara Robinson, MPH Epidemiologist Maine Center for Disease Control and Prevention.

Alan J. Siniscalchi, MPH, MS Influenza & Bioterrorism Surveillance Coordinator State of Connecticut Department of Public Health & the International Society.

Influenza in Alberta Season Kim Simmonds, Manager Infectious Disease Epidemiology Alberta Health 1.

Influenza-like Illness Visits & Influenza Labs as of December 10, 2012.

Influenza-like Illness (ILI) Surveillance Jim Cheek, MD, MPH, FACPM Director, Div of Epi & Disease Prev Indian Health Service

Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.

2012–2013 Influenza Season Epidemiology Lynn Sosa, MD Deputy State Epidemiologist Connecticut Department of Public Health 1.

U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.

Public Health Update David Kirschke, MD Medical Director / Health Officer Northeast Tennessee Regional Health Office.

Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.

HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,

Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.

Infectious Disease Epidemiology Section Office of Public Health Louisiana Department of Health and Hospitals

Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.

Response to pandemic (H1N1) Country experience - Japan Tomimasa Sunagawa Infectious Disease Surveillance Center National Institute.

Is for Epi Epidemiology basics for non-epidemiologists.

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Influenza A H1N1: A Pandemic in Real Time – What’s Next? Danny Chen, MD FRCPC MSc Infectious Disease Specialist Grand Rounds, York Central Hospital September.

Influenza-like Illness Surveillance at the National Level

Centers for Disease Control and Prevention Program title: Developing sustainable surveillance and response for seasonal and avian influenza. Goal: To establish.

Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,

Influenza Surveillance Update Health and Medical Subpanel Meeting July 13, 2010 Diane Woolard, VDH.

Mapping Influenza-Like Illness (ILI) Using Physician Claims Data Larry Svenson Public Health Surveillance and Environmental Health Branch Public Health.

Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.

Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.

Influenza Surveillance Danae Bixler, MD, MPH Infectious Disease Epidemiology Program.

Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.

Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.

Rotavirus Vaccine: use in Wisconsin, effects on primary care visits, hospitalizations, and laboratory detections Jonathan L. Temte, MD/PhD Associate Professor.

US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.

The Current Season: A Review of the Influenza Season Nancy J. Cox, Ph.D. Chief, Influenza Branch National Center for Infectious Diseases Centers.

1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.

Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit Swine Novel Pandemic Influenza A (H1N1) in Texas …OR How I Spent My Summer.

1 Using ESSENCE-FL and a serosurvey to estimate total influenza infections, 2009 Richard S. Hopkins, MD, MSPH Kate Goodin, MPH Mackenzie Weise, MPH Aaron.

INFLUENZA SURVEILLANCE Julie L Freshwater, MPH PhD Influenza Surveillance Coordinator.

Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.

National Mortality Surveillance: Building a Foundation Paul D. Sutton, Ph.D. Mortality Surveillance Team Lead NAPHSIS/NCHS Joint Meeting Phoenix, Arizona.

William W. Thompson, PhD Immunization Safety Office Office of the Chief Science Officer Centers for Disease Control and Prevention Impact of Seasonal Influenza.

Mr. C’s Joke/Riddle of the Day. The Role Canada is Playing How the World Keeps Diseases from Spreading Pt.2.

1 Division of Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO) Fifth Meeting of National Influenza Centres in the Western.

NVAC Influenza Vaccine Recommendations and Strategies Subgroup Members: Jerome Klein (Chair), Jeff Davis, Jon Abramson, Carolyn Bridges, Nancy Cox, Ben.

Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.

(CAREC) PAHO/WHO Serving 21 Member Countries in the English and Dutch Speaking Caribbean 2009 Pandemic Influenza in CAREC Member Countries: Summary and.

U.S. Outpatient Influenza-Like Illness Surveillance Network (ILINet) Neil Pascoe for Irene Brown.

Influenza Surveillance in the United States Oliver Morgan, PhD MSc Division of Emerging Infections and Surveillance Services Dr. Lyn Finelli, Scott Epperson.

Seasonal and Pandemic Influenza Research Activities National Vaccine Advisory Committee Meeting September 27, 2006 Barbara L. Mulach, Ph.D. National Institute.

THE PHILIPPINES’ RESPONSE TO PANDEMIC (H1N1) 2009 Presented by: Remigio M. Olveda, MD, Director National Influenza Center,Research Institute for Tropical.

INFLUENZA DIVISION Update on the Epidemiology and Clinical Features of Novel H1N1 Joseph Bresee, MD Chief, Epidemiology and Prevention Branch Influenza.

2009 Pandemic H1N1 Influenza Epidemiology April 2009 – January 2010 Preliminary.

Lisa Grohskopf, MD, MPH U.S. Influenza Surveillance Season National Center for Immunization & Respiratory Diseases Influenza Division U.S. Food.

1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 24 Public Health Surveillance.

Surveillance Update TISWG May, 2011 Rachel Wiseman, MPH Epidemiologist Emerging and Acute Infectious Diseases May 18, 2011.

Seoul Metropolitan Government Health & Welfare Headquarters Health Policy Division Kui-Nam Kim.

U.S. Influenza Surveillance Ann Moen Influenza Branch NCID/CDC.

CVD Testing the H1N1 Pandemic Flu Vaccines Mini-Med School Karen Kotloff, MD University of Maryland School of Medicine Center for Vaccine Development September.

Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.

The BioSense Influenza Module Craig Hales MD MPH, Roseanne English BS, Paul McMurray MDS, Michelle Podgornik MPH, Jerome Tokars MD MPH Centers for Disease.

May 2011 Influenza in the UK ( ) HPA Report ‘Surveillance of influenza & other respiratory viruses in the UK’ (May 2011)

Flu Update and Overview of Flu Surveillance in RI

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Establishment of Influenza Surveillance System in Liberia

Alan J. Siniscalchi, MPH, MS

The Role of NICs in Influenza Surveillance

Toby L. Merlin, M.D. Deputy Incident Manager CDC H1N1 Response

U.S. Influenza Sentinel Provider Surveillance Network

Influenza Vaccine Program Effectiveness in the United States

Presentation transcript:

U.S. Influenza Surveillance Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention

Evolving U.S. Influenza Surveillance Core Viruses –WHO / NRVESS Laboratory System Influenza-like illness –Sentinel Provider (SP) System Mortality –122 cities –NCHS State activity assessment –State & Territorial Epidemiologists Report Changes Underway Current systems –Enhancements to SP system New Systems Added –Pediatric influenza hospitalizations New Vaccine Surveillance Network Emerging Infections Program –Pediatric influenza deaths –H5N1 detection in ill travelers Under evaluation –Biosense –Notifiable diseases, etc.

Growth of the Influenza Sentinel Physician Surveillance System * Data as of 1/27/2005

Sentinel Provider System Coverage Map

Visits for Influenza-like Illness to U.S. Sentinel Providers,

2004 – 2005 U.S. Season

Influenza Virus Detections, U.S. WHO/NREVSS Collaborating Laboratories 58,286 Negative 1,041 (14.6%) Influenza B 1986 (32.7%) subtyped 6 (0.3%) H (99.7%) H3N2 65,404 specimens tested for influenza viruses 7,118 (10.9%) Positive 6,077 (85.4%) influenza A

U.S. WHO/NREVSS Collaborating Laboratories Summary,

Visits for Influenza-like Illness to U.S. Sentinel Providers,

NVSN Influenza (Lab Confirmed) Hospitalization Rates Children Years, This graph has been updated from the January 21, 2004 report due to laboratory confirmation of an additional influenza hospitalization between December 26, 2004 and January 8, 2005.

EIP Influenza (Lab Confirmed) Hospitalization Rates Children 0-4 years & 5-17 years,

Epidemic Threshold Seasonal Baseline Pneumonia and Influenza Mortality for 122 U.S. Cities Week Ending 2/05/

Weekly Influenza Activity Estimates Reported by State & Territorial Epidemiologists Week ending February 05, Week 5 No Report Sporadic Regional Widespread No Activity Local Activity

Conclusion Moderate impact compared with 2003 Dominated by A (H3N2) viruses 6 reported pediatric deaths Ongoing activity